Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage II Melanoma That Can Be Removed by Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a vaccine therapy for stage II melanoma patients eligible for surgical resection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Vaccine therapy

Snippet

Sponsor: University of Southern California | Conditions: Melanoma (Skin) | Phase 2 | Status: COMPLETED